Literature DB >> 24506502

Epimers of azaspiracids: Isolation, structural elucidation, relative LC-MS response, and in vitro toxicity of 37-epi-azaspiracid-1.

Jane Kilcoyne1, Pearse McCarron, Michael J Twiner, Ciara Nulty, Sheila Crain, Michael A Quilliam, Frode Rise, Alistair L Wilkins, Christopher O Miles.   

Abstract

Since azaspiracid-1 (AZA1) was identified in 1998, the number of AZA analogues has increased to over 30. The development of an LC-MS method using a neutral mobile phase led to the discovery of isomers of AZA1, AZA2, and AZA3, present at ~2-16% of the parent analogues in phytoplankton and shellfish samples. Under acidic mobile phase conditions, isomers and their parents are not separated. Stability studies showed that these isomers were spontaneous epimerization products whose formation is accelerated with the application of heat. The AZA1 isomer was isolated from contaminated shellfish and identified as 37-epi-AZA1 by nuclear magnetic resonance (NMR) spectroscopy and chemical analyses. Similar analysis indicated that the isomers of AZA2 and AZA3 corresponded to 37-epi-AZA2 and 37-epi-AZA3, respectively. The 37-epimers were found to exist in equilibrium with the parent compounds in solution. 37-epi-AZA1 was quantitated by NMR, and relative molar response studies were performed to determine the potential differences in LC-MS response of AZA1 and 37-epi-AZA1. Toxicological effects were determined using Jurkat T lymphocyte cells as an in vitro cell model. Cytotoxicity experiments employing a metabolically based dye (i.e., MTS) indicated that 37-epi-AZA1 elicited a lethal response that was both concentration- and time-dependent, with EC50 values in the subnanomolar range. On the basis of EC50 comparisons, 37-epi-AZA1 was 5.1-fold more potent than AZA1. This data suggests that the presence of these epimers in seafood products should be considered in the analysis of AZAs for regulatory purposes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24506502     DOI: 10.1021/tx400434b

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  6 in total

1.  A mussel tissue certified reference material for multiple phycotoxins. Part 5: profiling by liquid chromatography-high-resolution mass spectrometry.

Authors:  Elliott J Wright; Pearse McCarron
Journal:  Anal Bioanal Chem       Date:  2021-03-04       Impact factor: 4.142

2.  New insights into the causes of human illness due to consumption of azaspiracid contaminated shellfish.

Authors:  O P Chevallier; S F Graham; E Alonso; C Duffy; J Silke; K Campbell; L M Botana; C T Elliott
Journal:  Sci Rep       Date:  2015-04-30       Impact factor: 4.379

3.  Semiquantitation of Paralytic Shellfish Toxins by Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry Using Relative Molar Response Factors.

Authors:  Jiangbing Qiu; Elliott J Wright; Krista Thomas; Aifeng Li; Pearse McCarron; Daniel G Beach
Journal:  Toxins (Basel)       Date:  2020-06-16       Impact factor: 4.546

4.  Effects of Temperature, Growth Media, and Photoperiod on Growth and Toxin Production of Azadinium spinosum.

Authors:  Jane Kilcoyne; Amy McCoy; Stephen Burrell; Bernd Krock; Urban Tillmann
Journal:  Mar Drugs       Date:  2019-08-22       Impact factor: 5.118

5.  Structure Elucidation and in Vitro Toxicity of New Azaspiracids Isolated from the Marine Dinoflagellate Azadinium poporum.

Authors:  Bernd Krock; Urban Tillmann; Éric Potvin; Hae Jin Jeong; Wolfgang Drebing; Jane Kilcoyne; Ahmed Al-Jorani; Michael J Twiner; Qun Göthel; Matthias Köck
Journal:  Mar Drugs       Date:  2015-10-30       Impact factor: 5.118

6.  Biological Effects of the Azaspiracid-Producing Dinoflagellate Azadinium dexteroporum in Mytilus galloprovincialis from the Mediterranean Sea.

Authors:  Maria Elisa Giuliani; Stefano Accoroni; Marica Mezzelani; Francesca Lugarini; Simone Bacchiocchi; Melania Siracusa; Tamara Tavoloni; Arianna Piersanti; Cecilia Totti; Francesco Regoli; Rachele Rossi; Adriana Zingone; Stefania Gorbi
Journal:  Mar Drugs       Date:  2019-10-22       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.